Explained: Aduhelm The New Drug To Treat Alzheimer's Disease

The United States Food and Drug Administration has approved Aduhelm for the treatment of Alzheimer's disease, a progressive neurodegenerative disease that destroys the brain's neurons and cells and impairs cognitive abilities and memory. 

Rony Dutta | Updated : Jun 09 2021, 05:03 PM
Share this Video

The United States Food and Drug Administration has approved Aduhelm for the treatment of Alzheimer's disease, a progressive neurodegenerative disease that destroys the brain's neurons and cells and impairs cognitive abilities and memory.